R--National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98027R00014
NAICS
541618 - Other Management Consulting Services
Classification Code
R410
Additional Details
Documents1
The National Institutes of Health (NIH), through its Office of Logistics and Acquisition Operations (OLAO), has issued a Sources Sought notice seeking information from qualified vendors to support the National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Funnel Commercialization Core. This procurement activity is classified under NAICS code 541618, "Other Management Consulting Services," and is identified by procurement number 75N98027R00014.
The primary objective of this initiative is to identify capable organizations that can provide specialized management consulting services to advance the commercialization of biomedical imaging and bioengineering innovations. The scope of work is expected to encompass strategic support for the NIBIB Innovation Funnel, focusing on facilitating the transition of promising biomedical technologies from research and development stages toward market readiness and adoption. The intended outcomes include accelerating the commercialization process, enhancing the impact of federally funded research, and supporting innovators in navigating regulatory, business development, and market entry challenges.
Key requirements for this opportunity likely include demonstrated expertise in technology commercialization, experience working with biomedical or bioengineering innovations, and the ability to deliver tailored consulting services that address the unique needs of early-stage technologies. Expected deliverables may involve the development of commercialization strategies, market analyses, regulatory pathway guidance, and support for intellectual property management and partnership development.
The contracting entity for this procurement is the NIH OLAO, a federal office within the Department of Health and Human Services. The notice is currently active, with a response deadline of April 12, 2026. Interested parties are encouraged to review the opportunity details and submit capability statements as requested. The primary point of contact for this notice is Melanie D. Suarez, who can be reached via email at [email protected].
This procurement is in the Sources Sought phase, indicating that the government is conducting market research to assess the availability and capability of potential vendors. No set-aside requirements or special considerations are specified in the notice at this time. Contractors with relevant experience in management consulting for biomedical innovation commercialization are encouraged to evaluate this opportunity for alignment with their capabilities and to respond accordingly.
Further information, including any attachments, can be accessed through the official SAM.gov opportunity listing at https://sam.gov/opp/5de733a0c97d42f9aa1c8af0903b6e22/view.